Skip to main content
JXN
NYSE Finance

Jackson 10-Q Details Q3 EPS of $12.37 and a $4.7B AOCI Hit to Book Value

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Neutral
Importance info
7
Price
$140.65
Mkt Cap
$9.526B
52W Low
$89.67
52W High
$143.27
52W Position info
57% above low
Off High info
1.8% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

JXN sits 57% above its 52-week low of $89.67.

Summary

Jackson's Q3 10-Q confirms $847 million of net income to common ($12.37 diluted) and $517 million of adjusted operating earnings, while a $2.2 billion after-tax AOCI loss pulled shareholders' equity down to $8.5 billion.


Key Events · Earnings and Guidance · JXN

  • Q3 Net Income Jumps to $847M

    Net income attributable to common shareholders was $847 million, or $12.37 per diluted share, versus $65 million ($0.92) a year earlier; adjusted operating earnings were $517 million ($7.55) versus $433 million ($6.16).

  • AOCI Loss Cuts Book Value

    Accumulated other comprehensive loss widened to $4,664 million from $2,470 million at December 31, 2025, taking total shareholders' equity to $8,481 million from $9,953 million.

  • Tax Valuation Allowance Up $538M

    The company added $538 million to its valuation allowance in the nine months ($431 million in Q3), bringing the total to $1,024 million on unrealized available-for-sale tax losses and charitable carryover.

  • Retail Annuity Sales Up 22%

    Total sales were $7,282 million in Q3 versus $6,365 million, led by RILA sales of $2,967 million (from $2,066 million) and fixed index annuity sales of $627 million (from $73 million).


Analysis · JXN · Finance

The headline numbers were already out today, but the full 10-Q shows what sits underneath them. Q3 net income to common was $847 million ($12.37 diluted) against $65 million a year ago, and adjusted operating earnings rose to $517 million ($7.55) from $433 million. The catch is the balance sheet: accumulated other comprehensive income fell to a $4,664 million loss from $2,470 million at year-end, cutting total shareholders' equity to $8,481 million from $9,953 million, and the company added $538 million to its tax valuation allowance in the nine months. That gap between a strong GAAP quarter and a shrinking book value is the real story for anyone valuing JXN on book. Capital return remains the offset: $838 million returned in the first nine months, a $1 billion buyback increase, and free capital generation of $856 million with a 2026 target at or above $1.2 billion.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, JXN was trading at $140.65 on NYSE in the Finance sector, with a market capitalization of approximately $9.5B. The 52-week trading range was $89.67 to $143.27. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

JXN - Latest Insights

JXN
Nov 03, 2026, 4:15 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $140.65
Real-time Price: $132.60 info
Change: -$8.05 (-6%) info
Market Cap: $8.759B info
JXN
Nov 03, 2026, 4:14 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $140.65
Real-time Price: $132.60 info
Change: -$8.05 (-6%) info
Market Cap: $8.759B info
JXN
Sep 17, 2026, 3:10 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $129.91
Real-time Price: $132.60 info
Change: +$2.69 (+2%) info
Market Cap: $8.759B info
JXN
Aug 03, 2026, 4:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $126.17
Real-time Price: $132.60 info
Change: +$6.43 (+5%) info
Market Cap: $8.759B info
JXN
Aug 03, 2026, 4:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $130.00
Real-time Price: $132.60 info
Change: +$2.60 (+2%) info
Market Cap: $8.759B info